Sudden hyposmia as a prevalent symptom of COVID-19 infection

Since December 2019, a novel coronavirus SARS-CoV-2 (Covid-19) outbreak emerged in Wuhan, China, and subsequently rapidly spread to several countries. As of March 26, 2020, 533.416 cases with 24.082 deaths have been confirmed worldwide. Currently, United States, China, and Italy respectively are the countries with the highest number of cases¹. In a study of 7,736 Covid-19 patients in China, of all the clinical symptoms, hyposmia was not reported in any patient². We report on 6 subjects from Padua, Italy, who presented with hyposmia as the only or main manifestation of Covid-19. All patients were considered as “healthy people” before they were screened because of close contact with a lab-confirmed case of Covid-19. None of the patients reported acute, chronic or seasonal upper airway disease before infection, in one case a four-day fever was present after the onset of hyposmia; two patients reported myalgia the day before the onset of hyposmia and a mild dry cough after the hyposmia. Since olfactory disorders have a significant impact on taste, hypogeusia was reported in almost all cases³. This study was approved by the local ethics committee and all subjects gave informed consent to participate in the study. Patient data and clinical features are summarized in Table 1. All patients underwent “le nez du vin” a supra-threshold six odours smell test that confirmed hyposmia in all cases⁴. The clinical manifestation of Covid-19 ranges from asymptomatic carrier status to severe pneumonia. Asymptomatic individuals in Covid-19 are those who are carriers of the virus but do not show clinical symptoms. Zou et al. documented that the viral load found in asymptomatic patients was similar to that found in symptomatic patients. Asymptomatic carriers of COVID-19 virus are able to transmit the disease in the same degree as symptomatic carriers⁵. In order to contain contagions is of supreme importance to identify asymptomatic patients because this subpopulation is one of the main factors contributing to the spread of this disease.

The onset of hyposmia during a Covid-19 outbreak should be considered as a warning sign of an infection that requires a diagnostic test for Covid-19 and the detection and quarantine of patient close contacts. More extensive studies will be needed to systematically assess the frequency of hyposmia among Covid-19 patients, its pathogenesis, duration and potential role as a marker of disease progression or severity.